COMMUNIQUÉS West-GlobeNewswire
-
Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope
30/10/2018 - 13:00 -
Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer
30/10/2018 - 13:00 -
CymaBay Announces the Initiation of the Seladelpar Global Phase 3 Registration Study (ENHANCE) for the Treatment of Primary Biliary Cholangitis and Additional Corporate Updates
30/10/2018 - 13:00 -
Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
30/10/2018 - 13:00 -
Tabula Rasa HealthCare’s CareKinesis Division Successfully Launched Medication Risk Management and Pharmacy Services for Rocky Mountain PACE
30/10/2018 - 12:41 -
Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update
30/10/2018 - 12:30 -
Spark Therapeutics to Host Conference Call on Tuesday, Nov. 6 at 8:30 a.m. ET to Discuss Third Quarter Results and Recent Business Highlights
30/10/2018 - 12:30 -
Trogarzo® Phase III Data Analysis Presented at HIV Drug Therapy Glasgow 2018: Patients not achieving primary endpoint at day 7 experienced clinical benefit by end of study
30/10/2018 - 12:30 -
Analyse des données de la phase III de Trogarzo(MD) présentée à HIV Drug Therapy Glasgow 2018: les patients n’ayant pas atteint le principal critère d’évaluation au jour 7 ont obtenu des bénéfices cliniques en cours d’étude
30/10/2018 - 12:30 -
EyePoint Pharmaceuticals Announces First Quarter Fiscal Year 2019 Financial Results Release Date and Conference Call Information
30/10/2018 - 12:30 -
Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as "Hot Topic"
30/10/2018 - 12:30 -
MyoKardia Shares Data from Ongoing Clinical Programs and Details Three New Research Programs at 2018 R&D Day
30/10/2018 - 12:30 -
Resonant to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, November 13th at 1:30 p.m. Pacific Standard Time
30/10/2018 - 12:05 -
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
30/10/2018 - 12:00 -
Rapid Micro Biosystems Announces New Chief Financial Officer
30/10/2018 - 12:00 -
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia (PDD)
30/10/2018 - 12:00 -
Hospital Authority of Hong Kong Selects Mach7 and Client Outlook for Enterprise Imaging Contract
30/10/2018 - 12:00 -
Aleafia Labs Partners on Cannabinoid Pharmacogenetics Study
30/10/2018 - 12:00 -
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
30/10/2018 - 12:00
Pages